Necroptosis Research Compounds: RIPK1, RIPK3, and MLKL Inhibitors Explained
Explore necroptosis inhibitors targeting the RIPK1-RIPK3-MLKL axis, from pioneering necrostatin-1 to GSK872 and necrosulfonamide, essential tools for inflammation and neurodegeneration research.